Wells Fargo’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2K | Buy |
7,620
+4,000
| +110% | +$9.56K | ﹤0.01% | 5363 |
|
|
2025
Q1 | $15.6K | Buy |
3,620
+2,000
| +123% | +$8.6K | ﹤0.01% | 5317 |
|
|
2024
Q4 | $13.9K | Buy |
1,620
+1,500
| +1,250% | +$12.9K | ﹤0.01% | 5357 |
|
|
2024
Q3 | $2.04K | Hold |
120
| – | – | ﹤0.01% | 5643 |
|
|
2024
Q2 | $1.81K | Sell |
120
-412
| -77% | -$6.22K | ﹤0.01% | 5646 |
|
|
2024
Q1 | $8.84K | Buy |
532
+50
| +10% | +$830 | ﹤0.01% | 5401 |
|
|
2023
Q4 | $7.71K | Buy |
482
+24
| +5% | +$384 | ﹤0.01% | 5452 |
|
|
2023
Q3 | $34.9K | Sell |
458
-114
| -20% | -$8.68K | ﹤0.01% | 5009 |
|
|
2023
Q2 | $37.5K | Buy |
572
+446
| +354% | +$29.2K | ﹤0.01% | 5252 |
|
|
2023
Q1 | $7.56K | Hold |
126
| – | – | ﹤0.01% | 5618 |
|
|
2022
Q4 | $2.94K | Hold |
126
| – | – | ﹤0.01% | 5587 |
|
|
2022
Q3 | $4K | Buy |
126
+2
| +2% | +$63 | ﹤0.01% | 5663 |
|
|
2022
Q2 | $3K | Sell |
124
-412
| -77% | -$9.97K | ﹤0.01% | 5946 |
|
|
2022
Q1 | $16K | Sell |
536
-262
| -33% | -$7.82K | ﹤0.01% | 5764 |
|
|
2021
Q4 | $68K | Buy |
+798
| New | +$68K | ﹤0.01% | 5393 |
|